DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT01043445

CompletedPhase NA

-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.

G Protein-coupled Receptor in the Intestine (GPR 119) Stimulated GLP-1 Secretion

Asset

GLP-1 / incretin class catch-all

Listed sites

1

Recruiting sites

—

Enrollment

8

actual

Study population

Healthy volunteers

Key I/E criteria

•Male•Healthy volunteers

Primary endpoint

•Effect of this newly discovered GPR 119 agonist on gut hormone responses

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT01043445
Org study IDGPR119

Timeline

Milestones

Study first posted2010-01-06estimated
Last update posted2014-10-09estimated
Study start2009-09 (month precision)
Primary completion2010-03actual (month precision)
Study completion2010-04actual (month precision)

Assets

Investigational agents

GLP-1 / incretin class catch-all

Study populations

Who this study enrolls

Healthy volunteers

Eligibility

Who can enroll

Minimum age18 Years
Maximum age30 Years
SexMale
Healthy volunteersAccepted

Inclusion criteria

•Healthy caucasians v- Normal OGTT (75 g of glucose) according to WHO's criteria
•Normal hemoglobin
•Informed consent

Exclusion criteria

•Liver disease (ALAT> 2x normal level)
•Nephropathy (s-creatinin >130 microM or albuminuria)
•Relatives with type 2 diabetes

Endpoints (2)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Other (unclassified)

2 endpoints
Primary/protocol endpoint/low confidence

The effect of this newly discovered GPR 119 agonist on gut hormone responses, in particular GLP-1 in response of the different meals administered to the subjects

Time frame:1 year

descriptive

Secondary/protocol endpoint/low confidence

Glucose homeostasis, gall bladder contraction in response of the different meals administered to the subjects

Time frame:1 year

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.